Summary
We studied the ability of nifedipine, a calcium antagonist, to limit infarct size in the closed chest, coronary embolized dog. Immediately after embolization141Ce labelled microspheres were administered into the left ventricle. Myocardium not receiving microspheres was considered to be the region at risk. The nifedipine group (10 dogs) received a bolus (16 μg/kg i.v. over 8 minutes as a loading dose) followed by continuous infusion (1,000 μg/24 hours) 10 min after embolization. The control group (9 dogs) received an equal volume of saline. Twenty-four hours after embolization the dogs were sacrificed, the heart sectioned into 4-mm slices and the slices were stained with tetrazolium to reveal the infarct. The region at risk was determined by autoradiography of the microspheres in the heart slices. Infarct and risk zone volume were determined by planimetric methods. The nifedipine group had a significantly smaller infarct volume to risk zone voluem ratio than the control group (38.7±4.7% vs. 79.5±4.3%, p<0.001). We conclude that nifedipine produces a sustained limitation of infarct size following permanent occlusion of a dog's coronary artery.
Similar content being viewed by others
References
Page DL, Caulfield JB, Kaster JA, Desanctis RW, Sanders CA (1971) Myocardial changes associated with cardiogenic shock. N Eng J Med 285:133–137
Roberts R, Husain A, Ambos HD, Olover GC, Cox JR Jr, Sobel BE (1975) Relation between infarct size and ventricular arrhythmia. Br Heart J 37:1169–1173
Bleifeld W, Mathey D, Hanrath P, Buss H, Effert S (1977) Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics. Circulation 55:303–311
Sobel BE, Bresnahan GF, Shell WE, Yoder RD (1972) Estimation of infarct size in man and its relation to prognosis. Circulation 46:640–648
Thompson PL, Fletcher EE, Katavatis V (1979) Enzymatic indices of myocardial infarction. Circulation 59:113–119
Henry PD, Shuchleib R, Borda LJ, Roberts R, Williamson JR, Sobel BE (1978) Effects of nifedipine on myocardial perfusion on ischemic injury in dogs. Circ Res 43(3):372–380
Geary GG, Smith GT, Suehiro GF, McNamara JJ (1982) Failure of nifedipine therapy to reduce myocardial infarct size in the baboon. Am J Cardiology 49:331–337
Selwyn AP, Welman E, Fox K, Klein M (1979) The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs. Circ Res 44:16–23
Stone PH, Antman EM, Muller JE, Braunwald E (1980) Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II. Hemodynamic effects and clinical applications. Ann Intern Med 93:886–904
Fleckenstein A, Grun G, Byon KY, Doring HJ, Tritthart H (1975) The basic Ca-antagonist actions of nifedipine on cardiac energy metabolism and vascular smooth muscle tone. In: Hashimoto K, Kimura E, Kobayashi T (eds) Proceedings of 1st International Nifedipine (Adalat) Symposium. Tokyo; University of Tokyo Press, 31–44
Miletich DJ, Becker GL, Albrecht RF, Holsnouser S, Seals C (1983) The effects of verapamil on oxygen consumption of beating and non-beating heart cells in culture. Federation Proceedings 42:1343 (Abstract)
Roberts R, Jaffe AS, Henry PD, Sobel BD (1981) Nifedipine and acute myocardial infarction. Herz 6:90–97
Chagrasulis RW, Downey JM (1977) Selective coronary embolization in closed chest dogs. Am J Physiology 233:335–357
Heymann MA, Payne BD, Hoffman JIE, Rudolph AM (1977) Blood flow measurements with radionuclide-labelled particles. Progress Cardiovasc Disease 20:55–79
Chambers DE, Yellon DM, Hearse DJ, Downey JM (1983) Infarct size reduction or delay. Flurbiprofen limits apparent infarct size after 6 hours of coronary occlusion in the dog, but not after 24 h of occlusion. Am J Cardiol 51:884–890
Nachlas MM, Shnitka TK (1963) Macroscopic identification of early myocardial infarction by alterations in dehydrogenase activity. Am J Pathology 42(4):379–405
Yellon DM, Hearse DJ, Maxwell MP, Chambers DE, Downey JM (1983) Sustained limitation of myocardial necrosis 24 hours after coronary occlusion: Studies with verapamil infusion in dogs with small myocardial infarct. Am J Cardiology 51:1409–1413
Reimer KA, Lowe JE, Jennings RB (1977) Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs. Circulation 55:581–587
DeBoer LWV, Strauss HW, Kloner RA, Rude RE, Davis RF, Maroko PR, Braunwald E (1980) Autoradiographic method for measuring the ischemic myocardium at risk: Effects of verapamil on infarct size after experimental coronary artery occlusion. Proc Natl Acad Sci 77:6121–6123
Fishhein MC, Meerbaum S, Rit J, Lando U, Kanmatsnse K, Hercier JC, Carday E, Gang W (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme technique. Am Heart J 101:593–600
Factor SM, Cho S, Kirk ES (1982) Non-specificity of triphenyl tetraxolium chloride (TTC) for the gross diagnosis of acute myocardial infarction. (Abst) Circulation 66:II-84
Klein HH, Pushmann P, Schaper J, Schaper W (1981) The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virch Archiv 393:287–297
Ahumada G, Roberts R, Sobel BE (1976) Evaluation of myocardial infarction with enzymatic indices. Prog Cardiovas Dis 18:405–420
Schaper W (1978) Experimental coronary artery occlusion III. The determinants of collateral blood flow in acute coronary occlusion. Basic Res Cardiol 73:584–594
Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC (1981) Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs. Circ Res 49:685–700
Becker LC, Schuster EH, Jugdutt BI, Hutchins GM, Bulkley BH (1983) Relationship between myocardial infarct size and occluded bed size in the dog: Difference between left anterior descending and circumflex coronary artery occlusions. Circulation 67:549–557
Rasmussen MM, Reimer KA, Kloner RA, Jennings RB (1977) Infarct size reduction by propranolol before and after coronary ligation in dogs. Circulation 56:794–798
Melin JA, Becker LC (1983) Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction. Am Coll Cardiol 2:279–286
Jugdutt BI, Hutchins GM, Buckley BH, Becker LC (1980) Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog. Am J Cardiol 46:74–82
Patterson R, Kirk ES (1980) Apparent improvement in canine collateral myocardial blood flow during vasodilation depends on criteria used to identify ischemic myocardium. Circ Res 47:108–116
Majid PA, Jong JD (1982) Acute hemodynamic effects of nifedipine in patients with ischemic heart disease. Circulation 65:1114–1118
Weintraub WS, Hattori S, Agarwal JB, Helfant RH (1982) The effects of nifedipine on myocardial blood flow and contraction during ischemia in the dog. Circulation 65:49–53
Weintraub WS, Hattori S, Agarwal JB, Bodenheimer MM, Silver MM, Banka VS, Helfant RH (1981) Effect of nifedipine on myocardial blood flow by layer in normal, ischemic, and lateral border zones (Abstract). Circulation 64(4):IV-281
Author information
Authors and Affiliations
Additional information
Supported by grants from USPHS, Number HL20648 (USA) and Medical Research Council (Great Britain).
Rights and permissions
About this article
Cite this article
Yoshida, S., Downey, J.M., Friedman, F.R. et al. Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs. Basic Res Cardiol 80, 76–87 (1985). https://doi.org/10.1007/BF01906746
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01906746